URRMA R & D has a total of 20 patent applications. Its first patent ever was published in 2002. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are ADALTA PTY LTD, REPROPHARM and SHANGHAI NAT ENG RES CENTER OF ANTIBODY MEDICINE CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 3 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Argentina | 1 | |
#5 | Australia | 1 | |
#6 | Brazil | 1 | |
#7 | Canada | 1 | |
#8 | Chile | 1 | |
#9 | China | 1 | |
#10 | France | 1 | |
#11 | Israel | 1 | |
#12 | Republic of Korea | 1 | |
#13 | Morocco | 1 | |
#14 | Mexico | 1 | |
#15 | Tunisia | 1 | |
#16 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Haslin Camille | 16 |
#2 | Chermann Jean-Claude | 13 |
#3 | De Oliveira Ricardo | 5 |
#4 | Chermann Jean Claude | 3 |
#5 | Chermann Jean-Claude Haslin Ca | 1 |
#6 | Jean-Claude Chermann | 1 |
#7 | Camille Haslin | 1 |
Publication | Filing date | Title |
---|---|---|
AU2008228246A1 | Novel human anti-R7V antibodies and uses thereof | |
FR2836146A1 | IMMUNOGLOBULIN IgG3 PROTECTIVE MARKER FOR INFECTIOUS VIRAL DISEASES AND USES THEREOF |